Skip to main content
OpenTrials

Clinical trial condition

Atopic Dermatitis

Explore clinical trials studying Atopic Dermatitis. Study availability and eligibility vary by location and protocol.

857 public trials 113 recruiting studies
Refine in advanced search Browse all conditions

Atopic Dermatitis trial results

Completed

A Study to Assess the Safety, Tolerability, and Efficacy of Rocatinlimab in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)

NCT05633355

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Phoenix Childrens Hosptial Phoenix, Arizona, United States
  • Medical Advancement Centers of Arizona Tempe, Arizona, United States
  • Dermatology Trial Associates Bryant, Arkansas, United States
  • Little Rock Allergy and Asthma Clinical Research Center Little Rock, Arkansas, United States
View all 77 locations
View Trial Details
Completed

A Study Assessing Rocatinlimab on Vaccine Antibody Response in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET - VOYAGER)

NCT05899816

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations
  • Affiliated Dermatology Scottsdale, Arizona, United States
  • Center for Dermatology and Plastic Surgery Scottsdale, Arizona, United States
  • Scottsdale Clinical Trials Scottsdale, Arizona, United States
  • Medical Advancement Centers of Arizona Tempe, Arizona, United States
View all 85 locations
View Trial Details
Completed

A Study Evaluating Rocatinlimab in Moderate-to-severe Atopic Dermatitis (ROCKET-IGNITE)

NCT05398445

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Cahaba Dermatology and Skin Health Center Birmingham, Alabama, United States
  • Alliance Dermatology and Mohs Center Phoenix, Arizona, United States
  • Anaheim Clinical Trials Anaheim, California, United States
  • First OC Dermatology Fountain Valley, California, United States
View all 202 locations
View Trial Details
Completed

A Single-ascending Dose (Part A) and Repeat-dose (Part B) Study to Investigate the Safety, Pharmacokinetics and Efficacy (Part B Only) of UCB1381 in Healthy Study Participants (Part A) and in Study Participants With Moderate to Severe Atopic Dermatitis (Part B)

NCT05277571

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Up0110 125 Beverly Hills, California, United States
  • Up0110 101 Glendale, California, United States
  • Up0110 116 Los Angeles, California, United States
  • Up0110 121 Northridge, California, United States
View all 16 locations
View Trial Details
Completed

Proof of Concept Study of Rilzabrutinib in Adult Patients With Moderate-to-severe Atopic Dermatitis

NCT05018806

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Antelope Valley Clinical Trials Site Number : 8400001 Northridge, California, United States
  • Asthma and Allergy Associates, PC Site Number : 8400008 Colorado Springs, Colorado, United States
  • Florida International Research Center Site Number : 8400002 Miami, Florida, United States
  • Skin Sciences, PLLC Site Number : 8400005 Louisville, Kentucky, United States
View all 31 locations
View Trial Details

Related conditions